NAD+ Side Effects: What You Need to Know Before Starting

Key Takeaways

• IV NAD+ therapy commonly causes flushing, nausea, and chest tightness during infusion — these are dose-rate dependent and usually resolve by slowing the drip
• Oral NAD+ precursors (NMN and NR) show minimal side effects in clinical trials at doses up to 2,000 mg/day for 12 weeks
• A 2024 systematic review of RCTs concluded NAD+ and NADH supplementation is safe in humans
• Side effects are generally mild and temporary, but certain populations should consult a physician before starting

Table of Contents

• Why NAD+ Side Effects Differ by Delivery Method
• IV NAD+ Therapy Side Effects
• Oral NMN Side Effects
• Oral NR (Nicotinamide Riboside) Side Effects
• Injectable NAD+ Side Effects
• Drug Interactions and Contraindications
• Who Should Avoid NAD+ Therapy?
• How to Minimize Side Effects
• FAQ
• Sources

Why NAD+ Side Effects Differ by Delivery Method

Not all NAD+ therapies are created equal when it comes to side effects. The delivery method — IV infusion, oral supplement, or subcutaneous injection — determines how fast NAD+ enters your system and at what concentration. That rate matters.

If you’re exploring peptide therapy options and considering adding NAD+, understanding these differences helps you choose the right approach. The molecule itself is naturally present in every cell of your body. The side effects come from how it’s delivered, not from NAD+ being inherently dangerous.

Think of it like water: drinking a glass is fine, but a fire hose to the face is a different experience. Same substance, different delivery.

For a broader look at what NAD+ does and why people use it, see our NAD+ benefits guide.

IV NAD+ Therapy Side Effects

IV NAD+ therapy involves infusing 250–500 mg of NAD+ directly into the bloodstream over 2–4 hours. This method produces the most noticeable side effects because your body receives a large dose of an enzymatically active molecule all at once.

Common Side Effects During Infusion

These reactions occur in a significant percentage of patients and are well-documented across clinical settings:

Nausea and abdominal discomfort — The most frequently reported side effect. Occurs in roughly 30–50% of patients receiving higher doses. Usually subsides within 30 minutes of slowing or pausing the infusion [1].

Flushing and warmth — A sensation of heat, particularly in the face, chest, and arms. This is a vasodilation response and is not dangerous. It typically fades as your body adjusts to the infusion rate [2].

Chest tightness or pressure — A common but alarming sensation. In most cases, this is a transient reaction to rapid NAD+ delivery and resolves by reducing infusion speed. However, if accompanied by sharp pain or shortness of breath, treatment should stop immediately and medical evaluation is warranted [3].

Lightheadedness — Related to the vasodilatory effects. Staying well-hydrated before your session reduces the likelihood.

Headache — Reported in approximately 15–25% of IV NAD+ sessions. Usually mild and resolves within hours [2].

Muscle cramping — Less common but documented, particularly in patients who are dehydrated or electrolyte-depleted before treatment.

Less Common Side Effects

• Injection site bruising or irritation
• Temporary fatigue following the session (paradoxically, before the energy-boosting effects kick in)
• Mild anxiety or restlessness during infusion
• Diarrhea (rare)

What Causes These Reactions?

The primary driver is infusion rate. When NAD+ enters the bloodstream faster than your cells can process it, the excess triggers vasodilation and smooth muscle responses. This is why experienced clinicians always start slowly and titrate up based on tolerance [1].

It’s similar to how some people experience flushing with niacin (vitamin B3) — NAD+ is metabolically related to niacin, and the mechanism overlaps.

Oral NMN Side Effects

Nicotinamide mononucleotide (NMN) is a direct NAD+ precursor taken as an oral supplement. Its side effect profile is substantially milder than IV therapy.

What Clinical Trials Show

A multicenter, double-blind, placebo-controlled trial tested NMN at 300, 600, and 900 mg/day for 60 days in healthy middle-aged adults. The study found no safety issues based on adverse event monitoring, laboratory results, and clinical measures. NMN was “well tolerated” across all dose groups [4].

A 12-week study of 250 mg/day NMN in men over 65 similarly reported no significant adverse events compared to placebo [5].

Reported Side Effects (Mostly Anecdotal)

• Mild GI discomfort (bloating, loose stools) in the first few days, particularly at higher doses
• Occasional headache during the first week
• Mild flushing (less intense than IV or niacin-related flushing)
• Sleep disruption when taken late in the day (NAD+ influences circadian rhythms)

Most GI effects resolve within the first week as the body adjusts. Taking NMN with food typically reduces digestive complaints.

What We Don’t Know Yet

The longest published NMN trial in humans ran 12 weeks [4]. We don’t have human safety data beyond that timeframe. Animal studies spanning longer periods haven’t raised red flags, but acknowledging this gap is fair [6].

Oral NR (Nicotinamide Riboside) Side Effects

NR has more published human trial data than NMN, with studies testing doses from 100 to 2,000 mg/day.

Clinical Trial Safety Data

A systematic review of NR clinical trials (doses up to 2,000 mg/day for 12 weeks) found the supplement was generally safe and well-tolerated [7]. The most commonly reported side effects were:

• Mild nausea (3–8% of participants)
• Headache (comparable to placebo in most studies)
• Fatigue (paradoxically reported in early days of supplementation)
• Skin flushing (mild, not as intense as niacin)

In the long-COVID trial testing NR at 1,000 mg/day for 12 weeks, adverse event rates were similar between NR and placebo groups, suggesting the side effects weren’t meaningfully different from taking a sugar pill [8].

A heart failure trial using NR at 1,000 mg twice daily (2,000 mg total) for 12 weeks reported no dose-limiting toxicities [9]. This is notable because heart failure patients are typically more sensitive to metabolic perturbations.

NR vs. Niacin: The Flushing Question

Many people confuse NR side effects with niacin side effects. Traditional niacin (nicotinic acid) causes intense flushing, itching, and GI distress at therapeutic doses. NR does not activate the same receptor (GPR109A) responsible for niacin flush [10].

If you’ve avoided NAD+ supplements because of bad experiences with niacin, NR and NMN are meaningfully different molecules with different side effect profiles.

Injectable NAD+ Side Effects

Subcutaneous NAD+ injections are a middle ground between IV therapy and oral supplements. The side effect profile reflects that positioning.

Common Side Effects

Injection site reactions — Redness, swelling, or tenderness at the injection site. This is the most common side effect and is typical of any subcutaneous injection. For tips on injection technique, see our guide on how to inject peptides — the same principles apply.

Mild nausea — Less intense than IV therapy but more common than oral supplements. Usually passes within 30 minutes.

Localized warmth or flushing — Around the injection site rather than systemic. Milder than IV-related flushing.

Temporary discomfort — NAD+ injections can sting more than typical peptide injections due to the solution’s pH.

Dosing Considerations

Injectable NAD+ is typically dosed at 50–200 mg per injection, 2–3 times per week. Side effects are dose-dependent — starting at the lower end and increasing gradually reduces reactions. This approach mirrors the general peptide side effects management strategy: start low, go slow.

Drug Interactions and Contraindications

NAD+ itself has relatively few documented drug interactions, but caution is warranted in several situations:

Potential Interactions

Blood pressure medications — NAD+ has vasodilatory effects. Combined with antihypertensives, this could potentially cause hypotension. Monitor blood pressure closely during initial treatments [1].

Diabetes medications — NAD+ influences insulin sensitivity and glucose metabolism. People on insulin or sulfonylureas should coordinate with their prescribing physician, as adjustments may be needed.

Chemotherapy agents — This is the most debated area. Some cancer cells may use NAD+ to fuel growth and resist treatment. While the evidence is mixed and still emerging, most oncologists recommend avoiding NAD+ supplementation during active cancer treatment [11].

Immunosuppressants — NAD+ modulates immune function through sirtuin pathways. Theoretical interactions exist with medications that suppress immune activity.

Supplements to Consider

NAD+ works alongside several cofactors. Deficiencies in these can affect how well your body uses supplemental NAD+:

• TMG (trimethylglycine) — NAD+ metabolism consumes methyl groups. Supplementing TMG can prevent methyl donor depletion.
• B vitamins — particularly B6 and folate, which support methylation pathways
• Magnesium — involved in hundreds of enzymatic reactions, including some NAD+-dependent ones

Who Should Avoid NAD+ Therapy?

Based on current evidence and clinical consensus, these groups should avoid or delay NAD+ therapy:

• People with active cancer — until more data clarifies NAD+‘s effect on tumor metabolism [11]
• Pregnant or breastfeeding women — insufficient safety data in these populations
• People with severe liver disease — NAD+ is extensively metabolized by the liver
• Those with uncontrolled blood pressure — vasodilatory effects could be problematic
• People with gout — NAD+ metabolism produces nicotinamide, which may affect uric acid levels

If you fall into any of these categories, discuss alternatives with your physician. Our guide on are peptides safe covers broader safety considerations for related therapies.

How to Minimize Side Effects

Whether you’re doing IV therapy, injections, or oral supplements, these strategies reduce the likelihood and severity of side effects:

For IV NAD+ Therapy

1. Hydrate well — Drink 32+ oz of water in the 2–3 hours before your appointment
2. Fast for 2–3 hours beforehand — An empty stomach reduces nausea risk
3. Start with a lower dose — First-timers should begin with 250 mg rather than 500 mg
4. Communicate with your provider — If you feel chest tightness or significant nausea, ask them to slow the drip rate immediately
5. Plan recovery time — Some people feel fatigued for 1–2 hours post-infusion before energy improves

If you’re interested in supervised NAD+ IV therapy, NAD+ therapy online can connect you with providers who offer proper medical oversight.

For Oral Supplements (NMN/NR)

1. Take with food — Reduces GI discomfort
2. Start at half the target dose for the first week
3. Take in the morning — NAD+ influences circadian rhythms and can disrupt sleep if taken at night
4. Add TMG — 500–1,000 mg to support methylation

For Injectable NAD+

1. Rotate injection sites — Reduces localized reactions. See peptide injection sites for best practices.
2. Start at 50 mg and increase by 25–50 mg per session as tolerated
3. Inject slowly — Fast injection increases stinging
4. Use proper reconstitution techniques — Follow the same sterile practices outlined in how to reconstitute peptides

What the Overall Safety Data Says

A 2024 systematic review of randomized controlled trials across multiple databases (PubMed, MEDLINE, Embase, Cochrane, Web of Science, and Scopus) concluded that NAD+ and NADH supplementation is “safe and effective when acting as a supplement to humans” [12].

A separate 2020 systematic review covering 1,545 articles (147 meeting inclusion criteria) found that NAD+ precursors had “a favourable outcome on several age-related disorders” with acceptable safety profiles across 34 clinical studies [13].

The evidence base is solid for short-to-medium-term safety. Long-term data (>12 months) in humans is still accumulating.

For broader context on peptide and supplement safety, our guides on peptide side effects and are peptides safe cover related ground.

Explore the evidence: See all 10 NAD+ studies in our research database, or browse the full peptide therapy statistics for 2026.

FAQ

Does NAD+ IV therapy make you feel sick?▼

Nausea is the most common complaint during IV NAD+ infusions, affecting roughly 30–50% of patients at standard doses. The severity depends almost entirely on infusion rate. A skilled provider will adjust the speed based on your tolerance. Most patients find that symptoms stay manageable when the drip is set appropriately. Fasting for 2–3 hours beforehand also helps significantly [1][2].

Are NMN supplements safe to take every day?▼

Clinical trials have tested daily NMN supplementation at doses up to 900 mg/day for 60 days with no safety concerns [4]. A 12-week trial at 250 mg/day also showed no adverse effects [5]. Daily use appears safe based on available data, though we don’t yet have published trials running longer than 12 weeks in humans.

Can NAD+ cause cancer or make cancer worse?▼

This is a legitimate concern that deserves a direct answer. Some cancer cells upregulate NAD+ synthesis to fuel rapid growth. Theoretically, boosting NAD+ could support this process. However, there’s no clinical evidence that NAD+ supplementation in healthy people increases cancer risk [11]. The concern is primarily for people with existing cancer. If you have active malignancy, avoid NAD+ supplementation until discussing with your oncologist.

What happens if you stop taking NAD+ supplements?▼

NAD+ levels return to baseline within days to weeks of stopping supplementation. There’s no withdrawal effect or rebound phenomenon documented in clinical studies. Your body naturally produces NAD+ — supplements boost what’s already there rather than creating dependency. Some people cycle NAD+ supplementation (e.g., 3 months on, 1 month off) though there’s no strong evidence that cycling is necessary.

Is NAD+ therapy worth the side effects?▼

For most people, the side effects are mild and temporary while the potential benefits span energy production, DNA repair, and healthy aging. The risk-benefit profile is generally favorable, especially for oral precursors which have very few side effects. IV therapy side effects are more noticeable but manageable with proper technique. If you want personalized guidance, a peptide therapy consultation can help determine if NAD+ is appropriate for your goals.

Sources

1. NAD IV Therapy Safety & Side Effects. Restore Hyper Wellness. Published January 2026. Restore
2. NAD IV Therapy Safety & Side Effects: What to Know. Peach IV Wellness. Peach IV
3. NAD Injections Side Effects: What to Expect. HubMed. HubMed
4. Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45:29-43. PubMed
5. Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8:5. Nature
6. Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795-806.
7. Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Sci Adv. 2023;9(29):eadi4862. Science
8. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. eClinicalMedicine. 2025. The Lancet
9. Wang DD, et al. Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction. JACC Basic Transl Sci. 2022;7(12):1183-1196.
10. Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr. 2008;28:115-130.
11. Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021;6:2.
12. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. BioMed Res Int. 2024. PubMed
13. Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020;132:110831. PubMed